Abstract Osteosarcoma (OS) is one of the most prevalent malignant cancers with lower survival and poor overall prognosis mainly in children and adolescents. Identifying the molecular mechanisms and OS stem cells (OSCs) as new concepts involved in disease pathogenesis and progression may potentially lead to new therapeutic targets. Therefore, therapeutic targeting of OSCs can be one of the most important and effective strategies for the treatment of OS. This review describes the new molecular targets of OS as well as novel therapeutic approaches in the design of future investigations and treatment
AbstractOsteosarcoma is the most common type of bone cancer, especially in children and young adults...
Despite the option of multimodal therapy in the treatment strategies of osteosarcoma (OS), the most ...
Although osteosarcoma (OS) is a rare malignancy, it is ranked among the leading causes of cancer-rel...
Osteosarcoma (OS) is a bone cancer mostly occurring in pediatric population. Current treatment regim...
Osteosarcoma (OS) is a class of cancer originating from bone, mainly afflicting children or young ad...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment strategies ...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma is the most common bone sarcoma, which mainly affects adolescents and young adults. Al...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma (OS) is the most common primary malignant bone tumor, which usually occurs in children ...
open10siThis work was supported by the Plan Nacional 2008–2011 (ISC III/FEDER (Miguel Servet Program...
Abstract Osteosarcoma (OS) is a highly prevalent bone malignancy among adolescents, accounting for 4...
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone. Although sta...
Mesenchymal stem cells (MSCs) are multipotent stem cells with significant potential for regenerative...
AbstractOsteosarcoma is the most common type of bone cancer, especially in children and young adults...
Despite the option of multimodal therapy in the treatment strategies of osteosarcoma (OS), the most ...
Although osteosarcoma (OS) is a rare malignancy, it is ranked among the leading causes of cancer-rel...
Osteosarcoma (OS) is a bone cancer mostly occurring in pediatric population. Current treatment regim...
Osteosarcoma (OS) is a class of cancer originating from bone, mainly afflicting children or young ad...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment strategies ...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma is the most common bone sarcoma, which mainly affects adolescents and young adults. Al...
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapi...
Osteosarcoma (OS) is the most common primary malignant bone tumor, which usually occurs in children ...
open10siThis work was supported by the Plan Nacional 2008–2011 (ISC III/FEDER (Miguel Servet Program...
Abstract Osteosarcoma (OS) is a highly prevalent bone malignancy among adolescents, accounting for 4...
Osteosarcoma (OS) is the most common type of primary solid tumor that develops in bone. Although sta...
Mesenchymal stem cells (MSCs) are multipotent stem cells with significant potential for regenerative...
AbstractOsteosarcoma is the most common type of bone cancer, especially in children and young adults...
Despite the option of multimodal therapy in the treatment strategies of osteosarcoma (OS), the most ...
Although osteosarcoma (OS) is a rare malignancy, it is ranked among the leading causes of cancer-rel...